Artivion, Inc. last reported quarterly results on Nov 5, 2026, for Q3 FY2026 (the quarter ended Sep 30, 2026): revenue of $123.8 million (+9.2% year over year) and diluted EPS of -$0.16. It usually reports 36–43 days after a quarter ends. Based on that pattern, the next release is estimated for around Feb 11, 2027.
Results for Q4 FY2026, the quarter ending around Dec 31, 2026. Expected on a Thursday. Based on last year's release for the same quarter on Feb 12, 2026. This is an estimate, not a date the company has announced.
Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 36–43 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.
| Released | Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|---|
|
Nov 5, 2026
36 days after quarter end
From press release
|
Q3 FY2026
ended Sep 30, 2026
|
124
+9.2%
|
-8
-221.9%
|
-0.16
-223.1%
|
|
Aug 6, 2026
37 days after quarter end
|
Q2 FY2026
ended Jun 30, 2026
|
126
+11.3%
|
-14
-1104.5%
|
-0.28
-1033.3%
|
|
May 7, 2026
37 days after quarter end
|
Q1 FY2026
ended Mar 31, 2026
|
116
+17.5%
|
1
+380.6%
|
0.03
+400.0%
|
|
Feb 12, 2026
43 days after quarter end
|
Q4 FY2025
ended Dec 31, 2025
|
116
+19.2%
|
2
+114.7%
|
0.05
+111.3%
|
|
Nov 6, 2025
37 days after quarter end
|
Q3 FY2025
ended Sep 30, 2025
|
113
+18.4%
|
7
+384.2%
|
0.13
+360.0%
|
|
Aug 7, 2025
38 days after quarter end
|
Q2 FY2025
ended Jun 30, 2025
|
113
+15.3%
|
1
+163.4%
|
0.03
+160.0%
|
|
May 5, 2025
35 days after quarter end
|
Q1 FY2025
ended Mar 31, 2025
|
99
+1.6%
|
-1
-106.7%
|
-0.01
-105.6%
|
|
Feb 24, 2025
55 days after quarter end
|
Q4 FY2024
ended Dec 31, 2024
|
97
+3.9%
|
-16
-314.7%
|
-0.42
-337.1%
|
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- AORT (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Kennesaw, GA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 784199
- Former names
- CRYOLIFE INC (until Jan 6, 2022)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.